Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Precision Drilling
PDS
5
New Fortress Energy
NFE
US OptionsDetailed Quotes
ABT250411P140000
- 3.12
- 0.000.00%
15min DelayClose Apr 11 16:00 ET
0.00High0.00Low
0.00Open3.12Pre Close0 Volume0 Open Interest140.00Strike Price0.00Turnover0.00%IV-4.50%PremiumApr 11, 2025Expiry Date9.02Intrinsic Value100Multiplier-6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma41.98Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Abbott Laboratories Newsroom
Abbott Laboratories' Earnings Call Highlights Robust Growth
RBC Capital Maintains Outperform on Abbott Laboratories, Raises Price Target to $145
Abbott Labs Is Maintained at Overweight by Wells Fargo
Abbott Labs Is Maintained at Overweight by Barclays
These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings
Demystifying Abbott Laboratories: Insights From 11 Analyst Reviews
Abbott Labs Is Maintained at Buy by Stifel
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $130 to $159
Jefferies Adjusts Price Target on Abbott Laboratories to $137 From $135, Keeps Hold Rating
Abbott Laboratories Analyst Ratings
TD Cowen Adjusts Price Target on Abbott Laboratories to $145 From $135, Keeps Buy Rating
BTIG Adjusts Price Target on Abbott Laboratories to $145 From $140, Keeps Buy Rating
Express News | Abbott Laboratories : Oppenheimer Raises Target Price to $140 From $134
Today's Analyst Rating | Morgan Stanley Cuts Its Price Target Cut on Microsoft to $472, Piper Sandler Cuts Its Price Target Cut on NVIDIA to $150
Citi Reaffirms Their Buy Rating on Abbott Laboratories (ABT)
Express News | Abbott Laboratories : Wells Fargo Raises Target Price to $147 From $136
Express News | Abbott Laboratories : Barclays Raises Target Price to $159 From $158
Express News | Abbott : Stifel Raises Target Price to $145 From $135
Morgan Stanley Raises Price Target on Abbott Laboratories to $127 From $117, Keeps Equalweight Rating
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC)
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
